ENDRA Life Sciences (NDRA) Other Non Operating Income: 2016-2021
Historic Other Non Operating Income for ENDRA Life Sciences (NDRA) over the last 5 years, with Dec 2021 value amounting to -$617,200.
- ENDRA Life Sciences' Other Non Operating Income fell 17335.41% to -$617,200 in Q4 2021 from the same period last year, while for Dec 2021 it was -$315,021, marking a year-over-year decrease of 3662.78%. This contributed to the annual value of -$690,800 for FY2024, which is 250.02% down from last year.
- Per ENDRA Life Sciences' latest filing, its Other Non Operating Income stood at -$617,200 for Q4 2021, which was down 8,121.66% from -$7,507 recorded in Q3 2021.
- ENDRA Life Sciences' Other Non Operating Income's 5-year high stood at $308,600 during Q1 2021, with a 5-year trough of -$617,200 in Q4 2021.
- For the 3-year period, ENDRA Life Sciences' Other Non Operating Income averaged around -$34,424, with its median value being -$2,069 (2019).
- Within the past 5 years, the most significant YoY rise in ENDRA Life Sciences' Other Non Operating Income was 4,563.74% (2021), while the steepest drop was 17,335.41% (2021).
- ENDRA Life Sciences' Other Non Operating Income (Quarterly) stood at -$373,935 in 2017, then surged by 95.46% to -$16,990 in 2018, then plummeted by 203.56% to -$51,575 in 2019, then spiked by 106.94% to $3,581 in 2020, then tumbled by 17,335.41% to -$617,200 in 2021.
- Its Other Non Operating Income stands at -$617,200 for Q4 2021, versus -$7,507 for Q3 2021 and $1,086 for Q2 2021.